Varicella-Zoster virus ORF9 is an antagonist of the DNA sensor cGAS.


Journal

The EMBO journal
ISSN: 1460-2075
Titre abrégé: EMBO J
Pays: England
ID NLM: 8208664

Informations de publication

Date de publication:
18 07 2022
Historique:
revised: 04 05 2022
received: 15 07 2021
accepted: 09 05 2022
pubmed: 8 6 2022
medline: 20 7 2022
entrez: 7 6 2022
Statut: ppublish

Résumé

Varicella-Zoster virus (VZV) causes chickenpox and shingles. Although the infection is associated with severe morbidity in some individuals, molecular mechanisms that determine innate immune responses remain poorly defined. We found that the cGAS/STING DNA sensing pathway was required for type I interferon (IFN) induction during VZV infection and that recognition of VZV by cGAS restricted its replication. Screening of a VZV ORF expression library identified the essential VZV tegument protein ORF9 as a cGAS antagonist. Ectopically or virally expressed ORF9 bound to endogenous cGAS leading to reduced type I IFN responses to transfected DNA. Confocal microscopy revealed co-localisation of cGAS and ORF9. ORF9 and cGAS also interacted directly in a cell-free system and phase-separated together with DNA. Furthermore, ORF9 inhibited cGAMP production by cGAS. Taken together, these results reveal the importance of the cGAS/STING DNA sensing pathway for VZV recognition and identify a VZV immune antagonist that partially but directly interferes with DNA sensing via cGAS.

Identifiants

pubmed: 35670106
doi: 10.15252/embj.2021109217
pmc: PMC9289529
doi:

Substances chimiques

Interferon Type I 0
Membrane Proteins 0
STING1 protein, human 0
Viral Proteins 0
DNA 9007-49-2
Nucleotidyltransferases EC 2.7.7.-
cGAS protein, human EC 2.7.7.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e109217

Subventions

Organisme : Wellcome Trust
ID : 100954
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12025
Pays : United Kingdom
Organisme : NEI NIH HHS
ID : T32 EY017271
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_00008/8
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12009
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : R56 NS064022
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NEI NIH HHS
ID : P30 EY008098
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS064022
Pays : United States

Informations de copyright

© 2022 The Authors. Published under the terms of the CC BY 4.0 license.

Références

J Virol. 2013 Mar;87(5):2868-81
pubmed: 23269791
Mol Cell. 2021 Feb 18;81(4):739-755.e7
pubmed: 33606975
Eur J Immunol. 2018 Jul;48(7):1120-1136
pubmed: 29572905
J Med Virol. 2003;70 Suppl 1:S56-8
pubmed: 12627489
J Virol. 2018 Jul 17;92(15):
pubmed: 29793951
Trends Mol Med. 2018 Oct;24(10):904-915
pubmed: 30115567
Nature. 2015 Apr 23;520(7548):553-7
pubmed: 25642965
Cell. 2018 Jul 12;174(2):300-311.e11
pubmed: 30007416
Nucleic Acids Res. 2014 Dec 16;42(22):e168
pubmed: 25300484
Nat Immunol. 2010 Nov;11(11):997-1004
pubmed: 20890285
Elife. 2019 May 15;8:
pubmed: 31090537
Eur J Immunol. 2018 Apr;48(4):605-611
pubmed: 29215161
Nat Commun. 2017 Feb 13;8:14392
pubmed: 28194029
J Virol. 2008 Jun;82(12):5825-34
pubmed: 18400847
Sci Signal. 2019 Nov 26;12(609):
pubmed: 31772125
Vet Microbiol. 2002 Apr 22;86(1-2):69-88
pubmed: 11888691
J Virol. 2010 Sep;84(18):9240-53
pubmed: 20631144
Adv Virus Res. 2018;100:355-378
pubmed: 29551142
Nat Commun. 2016 Feb 19;7:10680
pubmed: 26893169
Cell Rep. 2014 Feb 13;6(3):421-30
pubmed: 24462292
J Invest Dermatol. 2017 Oct;137(10):2101-2109
pubmed: 28647346
J Virol. 2013 May;87(9):5106-17
pubmed: 23427162
Med Microbiol Immunol. 2019 Aug;208(3-4):495-512
pubmed: 30805724
J Med Virol. 1998 Sep;56(1):91-8
pubmed: 9700639
Nature. 2018 Dec;564(7736):439-443
pubmed: 30405246
Front Immunol. 2020 Jan 24;11:1
pubmed: 32038653
J Mol Biol. 2020 Jan 17;432(2):552-568
pubmed: 31786265
J Gen Virol. 2015 Jun;96(Pt 6):1436-1445
pubmed: 26068188
J Virol. 2016 May 12;90(11):5329-5342
pubmed: 27009954
J Virol. 2015 Feb;89(4):2436-41
pubmed: 25473054
Nat Rev Mol Cell Biol. 2020 Sep;21(9):501-521
pubmed: 32424334
J Virol. 2005 Oct;79(20):12658-66
pubmed: 16188968
J Virol. 2001 Jul;75(13):6183-92
pubmed: 11390620
J Hyg (Lond). 1964 Dec;62:413-24
pubmed: 14239921
Cell Mol Immunol. 2011 Mar;8(2):181-8
pubmed: 21317915
Cell. 2010 Feb 5;140(3):397-408
pubmed: 20144762
Nat Rev Microbiol. 2014 Mar;12(3):197-210
pubmed: 24509782
Nature. 2017 Aug 24;548(7668):461-465
pubmed: 28738408
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Nature. 2017 Sep 21;549(7672):394-398
pubmed: 28902841
Nature. 2017 Aug 24;548(7668):466-470
pubmed: 28759889
Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7376-80
pubmed: 8394020
EMBO Rep. 2017 Oct;18(10):1707-1715
pubmed: 28801534
J Virol. 2007 Dec;81(23):13200-8
pubmed: 17913822
Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11946-11955
pubmed: 31142647
EMBO J. 2022 Jul 18;41(14):e109217
pubmed: 35670106
Nucleic Acids Res. 2019 Jul 2;47(W1):W402-W407
pubmed: 31251384
PLoS Pathog. 2021 Jul 6;17(7):e1009689
pubmed: 34228767
Nat Protoc. 2007;2(12):3278-84
pubmed: 18079728
PLoS Pathog. 2018 Apr 30;14(4):e1006999
pubmed: 29709039
J Virol. 2003 Apr;77(8):4950-9
pubmed: 12663800
Curr Opin Neurol. 2014 Jun;27(3):356-60
pubmed: 24792344
Science. 2019 Mar 8;363(6431):
pubmed: 30846571
J Biol Chem. 2011 May 20;286(20):17921-33
pubmed: 21385879
Cell Host Microbe. 2015 Sep 9;18(3):333-44
pubmed: 26320998
J Virol. 2011 Nov;85(21):11079-89
pubmed: 21835786
Cell Biosci. 2016 Mar 16;6:21
pubmed: 26985360
Science. 2013 Feb 15;339(6121):786-91
pubmed: 23258413
Nat Immunol. 2004 Jul;5(7):730-7
pubmed: 15208624
Immunity. 2013 Dec 12;39(6):1019-31
pubmed: 24332030
Science. 2013 Feb 15;339(6121):826-30
pubmed: 23258412
Annu Rev Virol. 2019 Sep 29;6(1):567-584
pubmed: 31283436
Nat Rev Immunol. 2015 Feb;15(2):87-103
pubmed: 25614319
J Virol. 2018 Jul 17;92(15):
pubmed: 29793952
Cell Rep. 2013 May 30;3(5):1362-8
pubmed: 23707061
Cell Microbiol. 2006 Mar;8(3):387-400
pubmed: 16469052
Front Microbiol. 2018 Oct 12;9:2448
pubmed: 30369921
Microbiol Immunol. 2000;44(12):1027-31
pubmed: 11220676
Annu Rev Med. 2016;67:323-36
pubmed: 26526766
J Virol. 2019 May 29;93(12):
pubmed: 30918075
J Immunol. 2013 Mar 1;190(5):2311-9
pubmed: 23345332
Mol Cell. 2021 Jul 1;81(13):2823-2837.e9
pubmed: 34015248
Science. 2018 Aug 17;361(6403):704-709
pubmed: 29976794
Adv Immunol. 2017;133:121-169
pubmed: 28215278
Cell. 2004 Dec 29;119(7):915-26
pubmed: 15620351
Mol Cell. 2015 Sep 17;59(6):891-903
pubmed: 26300263
Science. 2006 Jan 13;311(5758):239-42
pubmed: 16339411
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W337-43
pubmed: 24799431
Pathogens. 2013 May 13;2(2):364-82
pubmed: 25437040
J Mol Biol. 1995 Mar 31;247(3):443-58
pubmed: 7714900
J Virol. 2019 Jan 17;93(3):
pubmed: 30404793
Annu Rev Immunol. 2015;33:257-90
pubmed: 25581309
Wkly Epidemiol Rec. 2014 Jun 20;89(25):265-87
pubmed: 24983077
J Infect Dis. 1986 Sep;154(3):422-9
pubmed: 3016110
Science. 2015 Sep 11;349(6253):1228-32
pubmed: 26229117
Cell Syst. 2018 Dec 26;7(6):627-642.e6
pubmed: 30471916
Methods Enzymol. 2019;625:13-40
pubmed: 31455523

Auteurs

Jonny Hertzog (J)

MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Wen Zhou (W)

Department of Microbiology, Harvard Medical School, Boston, MA, USA.
Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.

Gerissa Fowler (G)

MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Rachel E Rigby (RE)

MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Anne Bridgeman (A)

MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Henry Tw Blest (HT)

MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Chiara Cursi (C)

MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Lise Chauveau (L)

MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Tamara Davenne (T)

MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Benjamin E Warner (BE)

Department of Ophthalmology, University of Pittsburgh, Pittsburgh, PA, USA.

Paul R Kinchington (PR)

Department of Ophthalmology, University of Pittsburgh, Pittsburgh, PA, USA.
Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA, USA.

Philip J Kranzusch (PJ)

Department of Microbiology, Harvard Medical School, Boston, MA, USA.
Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.
Parker Institute for Cancer Immunotherapy, Dana-Farber Cancer Institute, Boston, MA, USA.

Jan Rehwinkel (J)

MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH